TY - JOUR
T1 - Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion
AU - Jeong, Yea Ji
AU - Knutsdottir, Hildur
AU - Shojaeian, Fatemeh
AU - Lerner, Michael G.
AU - Wissler, Maria F.
AU - Henriet, Elodie
AU - Ng, Tammy
AU - Datta, Shalini
AU - Navarro-Serer, Bernat
AU - Chianchiano, Peter
AU - Kinny-Köster, Benedict
AU - Zimmerman, Jacquelyn W.
AU - Stein-O’Brien, Genevieve
AU - Gaida, Matthias M.
AU - Eshleman, James R.
AU - Lin, Ming Tseh
AU - Fertig, Elana J.
AU - Ewald, Andrew J.
AU - Bader, Joel S.
AU - Wood, Laura D.
N1 - Publisher Copyright:
© 2023, Jeong et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.
PY - 2023/4/17
Y1 - 2023/4/17
N2 - Pancreatic ductal adenocarcinoma (PDAC) frequently presents with metastasis, but the molecular programs in human PDAC cells that drive invasion are not well understood. Using an experimental pipeline enabling PDAC organoid isolation and collection based on invasive phenotype, we assessed the transcriptomic programs associated with invasion in our organoid model. We identified differentially expressed genes in invasive organoids compared with matched noninvasive organoids from the same patients, and we confirmed that the encoded proteins were enhanced in organoid invasive protrusions. We identified 3 distinct transcriptomic groups in invasive organoids, 2 of which correlated directly with the morphological invasion patterns and were characterized by distinct upregulated pathways. Leveraging publicly available single-cell RNA-sequencing data, we mapped our transcriptomic groups onto human PDAC tissue samples, highlighting differences in the tumor microenvironment between transcriptomic groups and suggesting that non-neoplastic cells in the tumor microenvironment can modulate tumor cell invasion. To further address this possibility, we performed computational ligand-receptor analysis and validated the impact of multiple ligands (TGF-β1, IL-6, CXCL12, MMP9) on invasion and gene expression in an independent cohort of fresh human PDAC organoids. Our results identify molecular programs driving morphologically defined invasion patterns and highlight the tumor microenvironment as a potential modulator of these programs.
AB - Pancreatic ductal adenocarcinoma (PDAC) frequently presents with metastasis, but the molecular programs in human PDAC cells that drive invasion are not well understood. Using an experimental pipeline enabling PDAC organoid isolation and collection based on invasive phenotype, we assessed the transcriptomic programs associated with invasion in our organoid model. We identified differentially expressed genes in invasive organoids compared with matched noninvasive organoids from the same patients, and we confirmed that the encoded proteins were enhanced in organoid invasive protrusions. We identified 3 distinct transcriptomic groups in invasive organoids, 2 of which correlated directly with the morphological invasion patterns and were characterized by distinct upregulated pathways. Leveraging publicly available single-cell RNA-sequencing data, we mapped our transcriptomic groups onto human PDAC tissue samples, highlighting differences in the tumor microenvironment between transcriptomic groups and suggesting that non-neoplastic cells in the tumor microenvironment can modulate tumor cell invasion. To further address this possibility, we performed computational ligand-receptor analysis and validated the impact of multiple ligands (TGF-β1, IL-6, CXCL12, MMP9) on invasion and gene expression in an independent cohort of fresh human PDAC organoids. Our results identify molecular programs driving morphologically defined invasion patterns and highlight the tumor microenvironment as a potential modulator of these programs.
UR - http://www.scopus.com/inward/record.url?scp=85152622003&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85152622003&partnerID=8YFLogxK
U2 - 10.1172/JCI162054
DO - 10.1172/JCI162054
M3 - Article
C2 - 36881486
AN - SCOPUS:85152622003
SN - 0021-9738
VL - 133
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 8
M1 - e162054
ER -